| Patient | Hippocrates |
|---|---|
| Date of birth | 1937-01-10 |
| Identifiers | MRN HR-AC005-SYN; SSN (made up) 000-05-8153 |
| Document date | 2026-06-08 |
| Author | Eleni Vasquez-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Subsequent annual wellness visit. [S]
Hippocrates is an 89-year-old physician and teacher with bilateral knee osteoarthritis and low bone mass, who comes for his subsequent annual wellness visit, a year after his last one at his previous practice. He has finished twelve weeks of physical therapy and has started a tai chi class twice a week. He walks into town for his teaching again, stopping once on the hill instead of three times. He has had no falls. He uses diclofenac gel on his knees most mornings and acetaminophen a few times a week. He sleeps about six and a half hours without a sleep aid and naps after lunch. His cold in the spring cleared in ten days. He had the pneumococcal vaccine six weeks ago. He wants to put in writing what he would and would not want if he became seriously ill. [S]
| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit, age 89 |
| Mobility | Physical therapy finished; tai chi twice a week; no falls |
| Medicines | Diclofenac gel, acetaminophen as needed, vitamin D3 daily; no over-the-counter sleep aids or cold remedies |
| Mentation | Mini-Cog 5; PHQ-2 0 |
| What matters | Teaching, walking into town, and living in his own house |
Health risk assessment. Completed by the patient on paper at home and reviewed with him by Dr. Vasquez-Okafor at the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good for his age |
| Psychosocial | Lives alone; a neighbor looks in daily; pupils and friends visit; teaches two mornings a week |
| Tobacco | Never smoked |
| Alcohol and drugs | One small cup of watered wine with dinner (AUDIT-C 1); no other drugs |
| Physical activity | Walks into town most days; tai chi twice a week; home exercises |
| Nutrition | Regular meals; cheese and yogurt daily; weight steady |
| Sleep | Six and a half hours and an afternoon rest; no sleep aid |
| Activities of daily living | Independent |
| Instrumental activities of daily living | Independent in shopping, cooking, medicines and money |
| Home safety | Second stair rail and night lights fitted after the home safety check; smoke alarm working; no rugs on the stairs |
| Falls | No falls this year; one near-fall before intake; less fear of falling |
| Hearing and vision | Hears conversation well; reading glasses; eye examination eight months ago |
| Continence | Gets up once at night to pass urine; no leakage |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good; weight steady |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No hearing change; chews well |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | Regular bowels; no bleeding or heartburn |
| Genitourinary | Negative | Up once at night; good stream; no leakage |
| Musculoskeletal | Positive | Knee ache on the hill, 2 of 10 |
| Integumentary | Negative | No skin changes under the gel |
| Neurological | Negative | No dizziness or numbness |
| Psychiatric | Negative | Mood good; PHQ-2 0 |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen sodium 220 mg oral tablet, one or two tablets most days for knee pain, bought over the counter, for about two years; stopped at intake (Beers 2023: avoid chronic use) | One or two tablets by mouth up to twice a day, self-directed | Oral route | 2024-03-01 to 2026-03-02 | stopped | S |
| Diphenhydramine 25 mg oral capsule at bedtime three or four nights a week for sleep, bought over the counter; stopped at intake (Beers 2023: strongly anticholinergic) | One capsule at bedtime as needed, self-directed | Oral route | 2025-09-01 to 2026-03-02 | stopped | S |
| Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee pain, no more than 3,000 mg in a day | One to two tablets by mouth every eight hours as needed; no more than six tablets a day | Oral route | 2026-03-02 | active | S |
| Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily | One tablet by mouth daily | Oral route | 2026-03-02 | active | S |
| Diclofenac 1% gel, 4 g rubbed into each painful knee up to four times a day | Apply 4 g to each painful knee up to four times a day | Topical route | 2026-03-16 | active | S |
| Sodium chloride 0.65% nasal spray, two sprays in each nostril as needed for congestion | Two sprays in each nostril up to every four hours as needed | Nasal route | 2026-04-13 to 2026-04-23 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-08 | Body height | 168 | cm | S |
| 2026-06-08 | Body weight | 64.5 | kg | S |
| 2026-06-08 | Body mass index (BMI) [Ratio] | 22.9 | kg/m2 | S |
| 2026-06-08 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-06-08 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-06-08 | Heart rate | 64 | /min | S |
| 2026-06-08 | Respiratory rate | 16 | /min | S |
| 2026-06-08 | Body temperature | 36.5 | Cel | S |
| 2026-06-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-08 | Total score [Mini-Cog] | 5 | {score} | S | ||
| 2026-06-08 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
Vital signs recorded on 2026-06-08; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 64.5 kg, BMI 22.9; blood pressure 134/72 seated and 130/72 standing; pulse 64 and regular |
| Eyes | Reads the near card with his glasses |
| Ears, nose, mouth, and throat | Whispered voice heard in both ears |
| Musculoskeletal | Bony enlargement and crepitus of both knees; no effusion or warmth |
| Neurological | Gait steady; rises from a chair without using his arms |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Slower walking, knee pain on stairs and one near-fall in the past six months, found on the comprehensive geriatric assessment at intake: gait speed 0.78 m/s, Timed Up and Go 13.8 seconds, unable to hold a tandem stance for 10 seconds, grip 24 kg; cause under evaluation with a geriatric medicine consultation | resolved | confirmed | R26.81 | S — Synthetic presenting problem of normal aging found on a comprehensive geriatric assessment; superseded at the consultation, when knee osteoarthritis with reduced leg strength and balance was diagnosed. |
| Primary osteoarthritis of both knees, diagnosed clinically by the ACR criteria (knee pain, age over 50, morning stiffness under 30 minutes, crepitus, bony enlargement, no warmth), with reduced quadriceps strength and balance and an increased risk of falls; KOOS JR 62 | active | confirmed | M17.0 | S — Synthetic modern diagnosis made at the consultation: a common, mild condition of aging chosen for a figure with no documented illness; not a claim about his real knees. |
| Potentially inappropriate over-the-counter medicines (Beers 2023): naproxen most days for about two years and diphenhydramine for sleep three or four nights a week; both stopped at intake | resolved | confirmed | Z79.1 | S — Synthetic medication history found on the deprescribing review. |
| Low bone mass (femoral neck T-score -1.7, total hip -1.4) with vitamin D insufficiency (24 ng/mL); FRAX 10-year risk 11 percent major and 2.6 percent hip, below treatment thresholds | active | confirmed | M85.89 | S — Synthetic DXA finding at eight weeks; not a claim about his real bones. |
| Common cold (viral upper respiratory infection) with runny nose, sore throat and a mild cough, no fever, chest clear, oxygen saturation 97 percent; COVID-19 and influenza tests negative; resolved in about ten days | resolved | confirmed | J06.9 | S — Synthetic acute illness; not a historical claim. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 134/72 seated, 130/72 standing; no orthostatic fall |
| Falls risk (STEADI) | Up to date | At risk at intake; strength and balance program completed; repeat measures at the four-month review |
| Cognitive assessment | Completed today | Mini-Cog 5; MoCA 26 at intake |
| Depression screening | Completed today | PHQ-2 0 |
| Hearing | Completed today | Whispered voice heard in both ears |
| Vision and eye examination | Up to date | Eye examination eight months ago; reading glasses |
| Osteoporosis | Up to date | DXA six weeks ago: low bone mass, FRAX below treatment thresholds; repeat in two years |
| Colorectal cancer screening | Not indicated | Not recommended after 85 |
| Prostate cancer screening | Not indicated | Not recommended at 70 and older |
| Lung cancer screening and abdominal aortic aneurysm screening | Not indicated | Never smoked; beyond the age ranges |
| Diabetes and lipid screening | Not indicated | Beyond the screening age ranges; fasting glucose 92 mg/dL at intake |
| Hepatitis C and HIV screening | Not indicated | Beyond the screening age ranges and no risk factors |
| Unhealthy alcohol use | Completed today | AUDIT-C 1 |
| Pneumococcal vaccine | Up to date | PCV20 six weeks ago |
| RSV vaccine | Completed today | Single dose today (age 75 or older) |
| Recombinant zoster vaccine | Completed today | First dose today; second in two to six months |
| Influenza vaccine | Due | High-dose vaccine in the autumn |
| COVID-19 vaccine | Due | This season's dose in the autumn |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap eight years ago |
Immunizations given today: RSV vaccine (adjuvanted RSVpreF3), single dose for an adult aged 75 or older; Recombinant zoster vaccine, first of two doses [S]
Guideline basis: Age-Friendly Health Systems: the 4Ms (What Matters, Medication, Mentation, Mobility) (2026); Updating STEADI for Primary Care: Recommendations From the American Geriatrics Society Workgroup (2025); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Osteoporosis to Prevent Fractures: Screening (2025); Adult Immunization Schedule by Age (2026)
Follow-up: Four-month review in three weeks with repeat gait, balance and strength measures and vitamin D. Next annual wellness visit in one year. Next scheduled visit 2026-06-29: four-month review: knee function, repeat gait, balance and strength measures, vitamin D, falls and the home program. [S]
Voluntary advance care planning discussion of about 30 minutes, with his consent. He named a health care agent, a long-time friend, and completed an advance directive; the agent is recorded in the chart and is not named here. He said that what matters most to him is to think clearly, to teach, and to stay in his own house. If he became seriously ill with a good chance of recovery he wants full treatment, including a short stay in intensive care; if he could no longer recognize people or speak with them, he would want comfort-focused care at home and no resuscitation, mechanical ventilation or tube feeding. He asked to discuss a portable medical order at a later visit. [S]